Andlauer Healthcare Group Inc. (TSE:AND) Receives C$48.57 Average Target Price from Brokerages

Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is C$48.57.

A number of equities analysts recently weighed in on the stock. Scotiabank lifted their target price on shares of Andlauer Healthcare Group from C$43.00 to C$44.00 in a research note on Thursday, November 7th. TD Securities increased their price target on Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the stock a “buy” rating in a report on Thursday, November 7th.

View Our Latest Analysis on Andlauer Healthcare Group

Andlauer Healthcare Group Stock Up 2.0 %

Andlauer Healthcare Group stock opened at C$45.85 on Tuesday. The firm has a market cap of C$857.40 million, a price-to-earnings ratio of 30.16 and a beta of 0.66. Andlauer Healthcare Group has a 52-week low of C$36.43 and a 52-week high of C$46.01. The company has a debt-to-equity ratio of 41.86, a quick ratio of 1.66 and a current ratio of 1.35. The firm has a 50 day moving average price of C$42.98 and a two-hundred day moving average price of C$40.77.

Andlauer Healthcare Group Company Profile

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Read More

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.